Eliaz Therapeutics

Santa Rosa, United States

Eliaz Therapeutics is developing a novel treatment using targeted therapeutic apheresis to remove Galetin-3 from the body

$850K raised

May 2026

Equity Crowdfunding

Biotechnology Health Care Medical Device

Top Investors

National Institutes of Health

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Eliaz Therapeutics

How much funding has Eliaz Therapeutics raised?

Eliaz Therapeutics has raised $850K in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in May 2026.

Who are Eliaz Therapeutics's investors?

Eliaz Therapeutics's investors include National Institutes of Health.

Where is Eliaz Therapeutics headquartered?

Eliaz Therapeutics is headquartered in Santa Rosa, United States.

What does Eliaz Therapeutics do?

Eliaz Therapeutics is developing a novel treatment using targeted therapeutic apheresis to remove Galetin-3 from the body

What stage is Eliaz Therapeutics at?

Eliaz Therapeutics is at the Equity Crowdfunding stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 1, 2026.

MLA

"Eliaz Therapeutics — Funding & Investors." VCBacked, May 1, 2026, https://www.vcbacked.co/company/eliaz-therapeutics. Accessed June 3, 2026.

APA

VCBacked. (2026). Eliaz Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/eliaz-therapeutics

Wikipedia (cite web)

{{cite web |title=Eliaz Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/eliaz-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 1, 2026.

Similar Companies in Biotechnology